Genvor Inc (GNVR) stock
Close on Oct 19, 2026Market cap $22.19MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $22.19M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$3.45M
- EPS, diluted
- -$0.10
- Book value per share
- -$0.08
- Diluted shares
- 36M
Trading
- Previous close
- $0.68
- Open
- $0.61
- Day's range
- $0.61 – $0.61
- Volume
- 100
- Average volume (20 days)
- 3,783
Market cap history
Month-end market cap since 2023, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | GNVR | S&P 500 | Difference | GNVR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -2.4% | +0.6% | −3.0 pts | ||
| 3 months | +34.5% | +3.4% | +31.2 pts | ||
| Year to date | -38.5% | +13.3% | −51.8 pts | ||
| 1 year | -38.5% | +16.6% | −55.1 pts |
Five years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Press releases
Releases Genvor filed with the SEC as exhibits to Form 8-K or 6-K
About Genvor
Agricultural Production-Crops
Genvor Incorporated is an agricultural biotechnology company that develops peptide technologies to address challenges in crop protection, plant performance, and animal health. Utilizing an artificial intelligence platform called the BioCypher Algorithm, the company designs bioactive peptides, including antimicrobial peptides to combat bacterial, fungal, and viral plant pathogens, as well as nutritionally enhanced and crop-enhancing peptides to improve nutrient uptake and stress resilience. Genvor focuses on agricultural applications such as transgenic seed traits for major crops like corn, soybeans, and cotton, alongside topical foliar biopesticide sprays. It also explores animal nutrition applications to enhance feed efficiency in poultry, swine, and aquaculture. Its target customers and commercial partners include agricultural organizations and growers across conventional and organic markets.
Company profile, executives and historyGenvor stock: common questions
What is Genvor's stock price?
GNVR closed at $0.61 on Oct 19, 2026, down 9.89% on the day.
What is Genvor's market cap?
Genvor was worth $22.19M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is GNVR's P/E ratio?
Genvor lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.10), so it has no meaningful P/E ratio.
Does Genvor pay a dividend?
No. Genvor has not paid a cash dividend over the last twelve months.
How has GNVR stock performed over the past year?
Including dividends, GNVR returned -38.5% over the past year, against +16.6% for the S&P 500.
Who are Genvor's competitors?
Companies most similar to Genvor by business, industry and size include SEED, CTVA, ESGH, AGRZ, LND.
See a number that looks wrong?